Abiopharma

🔍 Gottwald James T. (Executive)

Company: TREDEGAR CORP (TG)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Sold 4,318 shares of Tredegar Common Stock at $8.118 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 361,920.00 | transaction_form_type: 4 | Footnotes: F5, F4
• Holds 0 shares of Tredegar Common Stock (Direct)
  Date: 2026-08-19 | Code: H | shares_owned_after: 40,000.00
• Holds 0 shares of Tredegar Common Stock (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: Footnote | shares_owned_after: 847,469.00 | Footnotes: F1
• Holds 0 shares of Tredegar Common Stock (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: Footnote | shares_owned_after: 10,000.00 | Footnotes: F2
• Holds 0 shares of Tredegar Common Stock (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: Footnote | shares_owned_after: 90,000.00 | Footnotes: F3

Footnotes:

• F1: Held as co-trustee FBO (among others) reporting person's family u/w Floyd D. Gottwald.
• F2: Owned by spouse. (Reporting person disclaims beneficial ownership.)
• F3: Held by me as co-trustee of the John D. Gottwald Family Trust. (Reporting person disclaims beneficial ownership.)
• F4: Held as co-trustee of the Residual 10-year CLAT UA FDGJR Living Trust.
• F5: Represents weighted sales price. The shares sold at prices ranging from $8.01 to $8.20. The reporting Person will provide upon request to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.